The alpha 1-adrenergic agonist methoxamine and the "loop" diuretic frusemide reduce nasal potential difference.

Abstract

Pretreatment by inhalation with the alpha 1-adrenergic agonist methoxamine and the "loop" diuretic frusemide reduces the bronchial response to certain airway challenges in asthma. To test whether these drugs may act by altering airway epithelial ion and water transport, their effect on nasal potential difference (PD) when applied topically in eight normal… (More)

Topics

Cite this paper

@article{Wood1991TheA1, title={The alpha 1-adrenergic agonist methoxamine and the "loop" diuretic frusemide reduce nasal potential difference.}, author={A M Wood and A T Dinh Xuan and Gina H Cremona and Alain Lockhart and Timothy W Higenbottam}, journal={The European respiratory journal}, year={1991}, volume={4 7}, pages={802-6} }